Practical, regulatory and clinical considerations for development of inhalation drug products

The formulation and device collectively constitute an inhalation drug product. Development of inhaled drugs must consider the compatibility between formulation and device in order to achieve the intended pharmaceutical performance and usability of the product to improve patient compliance with treat...

Full description

Bibliographic Details

Published in:	Asian Journal of Pharmaceutical Sciences
Main Authors:	Shuguang Hou, Jiangyue Wu, Xu Li, Hong Shu
Format:	Article
Language:	English
Published:	Elsevier 2015-12-01
Subjects:	Pressurized metered dose inhaler (pMDI) Dry powder inhaler (DPI) Nebulizer Formulation Device Clinical application
Online Access:	http://www.sciencedirect.com/science/article/pii/S1818087615000690